Form 4: Cyclo Therapeutics Director Vivien Wong Acquires Shares in Lieu of Cash Compensation

Director Vivien Wong acquired 7,937 shares of Cyclo Therapeutics common stock on August 16, 2024, in lieu of cash compensation for the second quarter of 2024.

Summary

• On August 16, 2024, Vivien Wong, a director of Cyclo Therapeutics, Inc., acquired 7,937 shares of common stock.
• The shares were received in lieu of cash compensation under the company's non-employee director compensation policy.
• The grant reflects director compensation for the second quarter of 2024.
• The number of shares was calculated based on a closing price of $1.26 per share on August 16, 2024.
• Following the transaction, Wong directly owns 24,568 shares of Cyclo Therapeutics common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director taking shares instead of cash is generally a good sign, but the impact is likely minimal.

Positives

• Director's decision to take shares instead of cash may signal confidence in the company's future.

Industry Context

Director share acquisitions are common and can be seen as a positive sign, indicating confidence in the company's prospects. However, the impact is dependent on the size of the acquisition relative to the director's existing holdings and the overall market capitalization of the company.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholders as it signals director confidence.

Key Dates